This is a standard poison pill extension and price adjustment — no trading signal. Monitor for any subsequent 13D filings or other takeover-related activity that would trigger the rights.
Price Chart
Executive Summary
Aptevo Therapeutics filed an 8-K to amend its shareholder rights plan (poison pill), extending the expiration date by one year to October 23, 2027, and reducing the purchase price from $70 to $14.56 per one one-thousandth of a Preferred Share. This is a routine maintenance of a takeover defense mechanism with no immediate financial impact.
Key Facts
- Amendment No. 6 to the Rights Agreement extends the Final Expiration Date to October 23, 2027.
- The Purchase Price was reduced from $70 to $14.56 per one one-thousandth of a Preferred Share.
- The rights agreement was originally dated November 8, 2020.
- The rights agent is Broadridge Corporate Issuer Solutions, LLC.
Financial Impact
No financial impact; routine amendment to a shareholder rights plan with no cash consideration or change in outstanding securities.
Risk Factors
- The reduced purchase price lowers the threshold at which the rights become exercisable, potentially making a hostile takeover more expensive for an acquirer.
- No material risk identified from this routine amendment.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-430419 |
| Document: apvo-ex4_1.htm | 0001193125-26-430419 |
| Document: 0001193125-26-430419-index-headers.html | 0001193125-26-430419 |
| Document: 0001193125-26-430419-index.html | 0001193125-26-430419 |
| Document: 0001193125-26-430419.txt | 0001193125-26-430419 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 1d ago | 8-K | $1.50 | awaiting T+5 | — | $1.28 (−14.67%) |
Oct 23, 2026 4d ago | 8-K | $1.50 | awaiting T+5 | — | $1.28 (−14.67%) |
Oct 14, 2026 13d ago | 8-K | $1.73 $1.60 | ▼ −7.51% | ▼ −7.97% | $1.28 (−26.01%) |
Sep 24, 2026 4w ago | 8-K | $1.83 $1.76 | ▼ −3.83% | ▼ −3.41% | $1.28 (−30.05%) |
Sep 3, 2026 7w ago | 424B4 / 8-K | $1.71 $1.82 | ▲ +6.43% | ▲ +7.58% | $1.28 (−25.15%) |
Sep 3, 2026 7w ago | EFFECT | $1.71 $1.82 | ▼ −6.43% | ▼ −7.58% | $1.28 (+25.15%) |
Aug 14, 2026 10w ago | 8-K | $2.94 $2.68 | ▼ −8.84% | ▼ −7.48% | $1.28 (−56.46%) |
Jul 27, 2026 13w ago | 8-K | $4.21 $3.95 | ▼ −6.18% | ▼ −8.44% | $1.28 (−69.60%) |
Jun 30, 2026 17w ago | 8-K | $4.45 $4.51 | ▲ +1.35% | ▲ +1.09% | $1.28 (−71.24%) |
May 6, 2026 24w ago | 8-K | $4.86 $4.76 | ▼ −2.06% | ▼ −3.56% | $1.28 (−73.66%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers